A detailed history of Sarasin & Partners LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Sarasin & Partners LLP holds 488,325 shares of TMO stock, worth $250 Million. This represents 2.85% of its overall portfolio holdings.

Number of Shares
488,325
Previous 560,176 12.83%
Holding current value
$250 Million
Previous $310 Million 2.5%
% of portfolio
2.85%
Previous 2.74%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$531.86 - $624.21 $38.2 Million - $44.9 Million
-71,851 Reduced 12.83%
488,325 $302 Million
Q2 2024

Jul 19, 2024

BUY
$541.52 - $599.02 $54.4 Million - $60.1 Million
100,383 Added 21.83%
560,176 $310 Million
Q1 2024

Apr 12, 2024

BUY
$528.82 - $599.43 $23.1 Million - $26.2 Million
43,678 Added 10.5%
459,793 $267 Million
Q4 2023

Jan 09, 2024

BUY
$431.41 - $532.94 $21.7 Million - $26.8 Million
50,372 Added 13.77%
416,115 $221 Million
Q3 2023

Oct 05, 2023

BUY
$498.29 - $574.41 $4.27 Million - $4.92 Million
8,570 Added 2.4%
365,743 $185 Million
Q2 2023

Jul 10, 2023

BUY
$508.46 - $591.13 $58.2 Million - $67.7 Million
114,497 Added 47.18%
357,173 $186 Million
Q1 2023

May 05, 2023

BUY
$535.0 - $604.82 $130 Million - $147 Million
242,676 New
242,676 $140 Million
Q4 2022

Jan 30, 2023

BUY
$484.71 - $571.37 $14.5 Million - $17.1 Million
29,865 Added 10.77%
307,223 $169 Million
Q3 2022

Oct 18, 2022

BUY
$507.19 - $604.49 $8.36 Million - $9.97 Million
16,490 Added 6.32%
277,358 $141 Million
Q2 2022

Jul 13, 2022

BUY
$500.9 - $612.21 $62.9 Million - $76.9 Million
125,631 Added 92.9%
260,868 $142 Million
Q1 2022

Apr 11, 2022

BUY
$524.0 - $644.92 $70.9 Million - $87.2 Million
135,237 New
135,237 $79.9 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Sarasin & Partners LLP Portfolio

Follow Sarasin & Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.